Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 235 | 353 | 10,386 | 0 | 10,455 |
| Gross Profit | 235 | 353 | 10,386 | N/A | 10,455 |
| Operating Expenses | 68,149 | 55,272 | 56,790 | 34,015 | 26,366 |
| Operating Income | -67,914 | -54,919 | -46,404 | -34,015 | -15,911 |
| Other Income | 3,892 | 4,522 | 1,061 | 238 | -319 |
| Pre-tax Income | -64,022 | -50,397 | -45,343 | -33,777 | -16,230 |
| Net Income Continuous | -64,022 | -50,397 | -45,343 | -33,777 | -16,230 |
| Minority Interests | 1 | -8 | -5 | -9 | -6 |
| Net Income | $-64,023 | $-50,389 | $-45,338 | $-33,768 | $-16,224 |
| EPS Basic Total Ops | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 |
| EPS Basic Continuous Ops | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 |
| EPS Diluted Total Ops | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 |
| EPS Diluted Continuous Ops | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 |
| EPS Diluted Before Non-Recurring Items | -0.86 | -0.94 | -1.60 | -1.77 | -1.77 |
| EBITDA(a) | $-69,079 | $-55,349 | $-44,176 | $-32,345 | $-14,189 |